Proteins with known 3D structures
Identification and Colliers de Perles: Human Immunoglobulins
Overview table Identification of the genes and alleles involved in the rearrangements and expressed in the variable regions Protein display of the Ig V-D-J and V-J-REGIONs

Click here to see: Part 2 - Human Ig kappa chains associated or not to a heavy chain
Click here to see: Part 3 - Human Ig lambda chains associated or not to a heavy chain

Part 1 - Human Ig heavy chains associated or not to a kappa or lambda chain

Reference of this table: Ruiz, M. and Lefranc, M.-P., Immunogenetics, 53, 857-883 (2002) PMID:11862387, LIGM:259

Updates from 09/05/2001 are available in IMGT/3Dstructure-DB. IMGT/3Dstructure-DB entries (cards) are identified by the PDB code.
Click on a PDB code to get the corresponding IMGT/3Dstructure-DB card.

Click on a PDB chain name to get the corresponding Protein display.
Click on the CDR-IMGT lengths to get the corresponding Collier de Perles.

The gene identification was automatically determined by comparing PDB amino acid sequences with the IMGT reference directory translated sequences, using the stand-alone BLAST program.

Protein name
PDB code
Heavy chain
Light chain
PDB chain name
IGH V-D-J-REGION
IGH C-REGION
PDB chain name
IGK or IGL V-J-REGION
IGK or IGL C-REGION
IGHV gene and allele name
IGHD gene and allele name
IGHJ gene and allele name
CDR-IMGT lengths
IGHC gene name
Exons
IGKV or IGLV gene and allele name
IGKJ or IGLJ gene and allele name
CDR-IMGT lengths
IGKC or IGLC gene name
17B 1g9m H IGHV1-69*02 or IGHV1-69*04   IGHJ1*01 [8.8.21] IGHG1 CH1 L IGKV3-15*01 or IGKV3D-15*01 IGKJ2*01 [6.3.11] IGKC
1g9n H L
1gc1 H L
3D6 1dfb H IGHV3-9*01   IGHJ3*01 or IGHJ3*02 [8.8.19] IGHG1 CH1 L IGKV1-5*03 IGKJ3*01 [6.3.7] IGKC
1obe H L
9E 1dx3 H IGHV7-4-1*02   IGHJ4*01 or IGHJ4*02 or IGHJ4*03 [8.8.9]     L IGKV3-11*01 IGKJ1*01 [6.3.10]  
B7-15A2 1aqk H IGHV3-30*01 or IGHV3-30*04 or IGHV3-30*07 or IGHV3-30*11 or IGHV3-30*14 or IGHV3-30*16 or IGHV3-30*17 or IGHV3-30-3*01   IGHJ3*02 [8.8.16] IGHG1 CH1 L IGLV1-40*01 IGLJ2*01 or IGLJ3*01 or IGLJ3*02 or IGLJ7*01 [9.3.10] IGLC3
Fab-12 1cz8 H IGHV7-4-1*02   IGHJ2*01 [8.8.16] IGHG1 CH1 L IGKV1-33*01 or IGKV1D-33*01 IGKJ1*01 [6.3.9] IGKC
1cz8 Y X
HULYS11 1bvk B IGHV4-59*01 or IGHV4-59*02   IGHJ4*01 or IGHJ4*02 or IGHJ4*03 [8.7.10]     A IGKV1-27*01 IGKJ1*01 [6.3.9]  
1bvk E D
1bvl A B
1bvl C D
Hil 8fab B IGHV3-33*01 or IGHV3-33*04   IGHJ4*01 or IGHJ4*02 or IGHJ4*03 [8.8.14] IGHG1 CH1 A IGLV3-25*02 IGLJ3*02 [6.3.9] IGLC2
8fab D C
Iga1 1iga A IGHV1-3*01   IGHJ4*01 or IGHJ4*02 or IGHJ4*03 [8.8.14] IGHA1 CH1 CH2 CH3 C IGKV1-13*02/1D-13*02 IGKJ4*01 [6.3.9] IGKC
1iga B D
IgmRf2A2 1dee B IGHV3-30*18   IGHJ4*01 or IGHJ4*02 or IGHJ4*03 [8.8.14] IGHM CH1 A IGKV1-39*01 or IGKV1D-39*01 IGKJ1*01 [6.3.9] IGKC
1dee D C
1dee F E
Kau Cold Agglutinin 1qlr B IGHV4-34*01 or IGHV4-34*02   IGHJ4*01 or IGHJ4*02 or IGHJ4*03 [8.7.14] IGHM CH1 A IGKV3D-20*01 IGKJ4*01 [7.3.9] IGKC
1qlr D C
Kol 2fb4 H IGHV3-33*01 or IGHV3-33*04   IGHJ6*01 or IGHJ6*02 [8.8.19] IGHG1 CH1 L IGLV1-44*01 IGLJ1*01 [8.3.11] IGLC1
2ig2 H L
M3C65 1dl7 H IGHV4-59*01   IGHJ4*01 or IGHJ4*02 or IGHJ4*03 [8.7.7]     L IGLV7-43*01 or IGLV7-46*01 IGLJ3*02 [9.3.9]  
Mak33 1fh5 H IGHV3-11*01 or IGHV3-11*03 or IGHV3-21*01 or IGHV3-21*02   IGHJ4*01 or IGHJ4*02 or IGHJ4*03 [8.8.7] IGHG1 CH1 L IGKV6-21*01 or IGKV6D-21*01 or IGKV6D-41*01 IGKJ4*01 [6.3.9] IGKC
Mcg 1mco H IGHV4-39*01 or IGHV4-39*06   IGHJ5*02 [10.7.9] IGHG1 CH1 CH2 CH3 L IGLV2-8*01 IGLJ1*01 [9.3.10] IGLC1
Mez 1dql H IGHV3-30*10   IGHJ3*01 or IGHJ3*02 [8.8.16]     L IGKV1-17*01 IGKJ1*01 [6.3.8]  
Newm 7fab H IGHV4-59*04   IGHJ6*01 or IGHJ6*02 [8.7.11] IGHG1 CH1 L IGLV1-40*01 IGLJ2*01 or IGLJ3*01 or IGLJ3*02 [9.3.9] IGLC3
Pot 1igm H IGHV3-23*01   IGHJ5*01 [8.8.14]     L IGKV1-33*01 or IGKV1D-33*01 IGKJ3*01 [6.3.9]  
Rf-An 1adq H IGHV3-9*01   IGHJ4*01 or IGHJ4*02 or IGHJ4*03 [8.8.16] IGHM CH1 L IGLV3-21*02 IGLJ2*01 or IGLJ3*01 or IGLJ3*02 or IGLJ7*01 [6.3.11] IGLC3
Tr1.9 1vge H IGHV1-3*01   IGHJ4*01 or IGHJ4*02 or IGHJ4*03 [8.8.14] IGHG1 CH1 L IGKV1-13*02/1D-13*02 IGKJ4*01 [6.3.9] IGKC
Undefined 1hou H IGHV3-23*01   IGHJ6*01 or IGHJ6*02 [8.8.8]     L IGKV2D-29*01 IGKJ1*01 [11.3.10]  

We thank Olga Posukh for her work in the gene and allele identification.


Created: 11/06/2001
Last updated: Monday, 11-Jul-2011 12:56:57 CEST
Author: Manuel Ruiz

Software material and data coming from IMGT server may be used for academic research only, provided that it is referred to IMGT®, and cited as "IMGT®, the international ImMunoGeneTics information system® http://www.imgt.org (founder and director: Marie-Paule Lefranc, Montpellier, France)." References to cite: Lefranc, M.-P. et al., Nucleic Acids Res., 27:209-212 (1999); doi: 10.1093/nar/27.1.209 Full text Cover; Ruiz, M. et al., Nucleic Acids Res., 28:219-221 (2000); doi: 10.1093/nar/28.1.219 Full text; Lefranc, M.-P., Nucleic Acids Res., 29:207-209 (2001); doi: 10.1093/nar/29.1.207 Full text; Lefranc, M.-P., Nucleic Acids Res., 31:307-310 (2003); doi: 10.1093/nar/gkg085 Full text; Lefranc, M.-P. et al., In Silico Biol., 5, 0006 (2004) [Epub], 5:45-60 (2005); Lefranc, M.-P. et al., Nucleic Acids Res., 33:D593-597 (2005); doi: 10.1093/nar/gki065 Full text; Lefranc, M.-P. et al., Nucleic Acids Res., 37:D1006-1012 (2009); doi: 10.1093/nar/gkn838 Full text; Lefranc, M.-P. et al., Nucleic Acids Res., 43:D413-422 (2015); doi: 10.1093/nar/gku1056 Full text.
For any other use please contact Marie-Paule Lefranc Marie-Paule.Lefranc@igh.cnrs.fr.

CNRS Université de Montpellier European Commission
IMGT® Founder and Executive Director Emeritus:
Marie-Paule Lefranc Marie-Paule.Lefranc@igh.cnrs.fr
IMGT® Director:
Sofia Kossida Sofia.Kossida@igh.cnrs.fr
Bioinformatics manager:
Véronique Giudicelli Veronique.Giudicelli@igh.cnrs.fr
Computer manager:
Patrice Duroux Patrice.Duroux@igh.cnrs.fr
Webmaster:
Amélie Houles

Citing IMGT | Warranty disclaimer and copyright notice | Privacy policy and advertisement policy

© Copyright 1995-2017 IMGT®, the international ImMunoGeneTics information system®